NCT05148026View on ClinicalTrials.gov

Regional Citrate Anticoagulation for RRT During V-V ECMO

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 14, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

January 31, 2026

Conditions
ARDS, HumanAcute Kidney Injury
Interventions
DRUG

Unfractionated heparin + RCA first

Patients are randomized to receive this sequence of anticoagulation regimens: UFH+RCA / UFH / UFH+RCA / UFH / UFH+RCA / UFH

DRUG

Unfractionated heparin first

Patients are randomized to receive this sequence of anticoagulation regimens: UFH / UFH+RCA / UFH / UFH+RCA / UFH / UFH+RCA

Trial Locations (1)

20900

RECRUITING

ASST MONZA-Rianimazione Generale, Monza

All Listed Sponsors
lead

University of Milano Bicocca

OTHER